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Background: Pioneering technologies (e.g., nanotechnology, synthetic biology or climate engineering) are often
associated with potential new risks and uncertainties that can become sources of controversy. The communication
of information during their development and open exchanges between stakeholders is generally considered a key
issue in their acceptance. While the attitudes of the public to novel technologies have been widely considered
there has been relatively little investigation of the perceptions and awareness of scientists working on human or
animal diseases transmitted by arthropods.
Methods: Consequently, we conducted a global survey on 1889 scientists working on aspects of vector-borne
diseases, exploring, under the light of a variety of demographic and professional factors, their knowledge and
awareness of an emerging biotechnology that has the potential to revolutionize the control of pest insect
populations.
Results: Despite extensive media coverage of key developments (including releases of manipulated mosquitoes
into human communities) this has in only one instance resulted in scientist awareness exceeding 50 % on a
national or regional scale. We document that awareness of pioneering releases significantly relied on private
communication sources that were not equally accessible to scientists from countries with endemic vector-borne
diseases (dengue and malaria). In addition, we provide quantitative analysis of the perceptions and knowledge of
specific biotechnological approaches to controlling vector-borne disease, which are likely to impact the way in
which scientists around the world engage in the debate about their value.
Conclusions: Our results indicate that there is scope to strengthen already effective methods of communication, in
addition to a strong demand by scientists (expressed by 79.9 % of respondents) to develop new, creative modes of
public engagement.
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Over the last 100 years there have been numerous dra-
matic successes in the control of devastating human dis-
eases vectored by insects, this includes the stable
elimination of malaria from almost 100 countries [1] and
the global control of urban yellow fever epidemics [2].* Correspondence: cboete@gmail.com
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to limit transmission [4, 5]. This has already resulted
in large-scale open field trials of two biotechnological
techniques in Australia, Indonesia, Vietnam, Cayman
Islands (U.K.) and Brazil with a species of mosquito
that is responsible for transmitting dengue to humans
around the globe (Aedes aegypti, [6–10]). The first of these
experimental approaches seeks to establish maternally
inherited endosymbiotic bacteria at high frequency in target
Aedes aegypti populations as a means to reduce their cap-
acity to vector a range of diseases. This anti-pathogen tech
nique was field trialed for the very first time in the Austra-
lian city of Cairns in 2011 and was largely developed by re-
searchers at Australian universities [8, 9]. The second
biotechnological technique uses a recombinant genetic en-
gineering approach to render released males partially sterile
as a means to reduce the size of target Aedes aegypti popu-
lations. This technique was largely developed by a commer-
cial company (Oxitec Ltd. based in the United Kingdom)
and was first field trialed in 2009 in the Caribbean Cayman
Islands [7]. This was only the second time a transgenic in-
sect had ever been intentionally released and was the first
release of a transgenic mosquito (the earlier series of trials
had released a transgenic moth pest of cotton in the USA,
[11, 12]). Both the transgenic and the Wolbachia ap-
proaches require the release of large numbers of manipu-
lated mosquitoes into human communities. These
techniques, and other related biotechnological approaches
have been argued as having the potential to positively
revolutionize the control of diseases vectored by insects to
humans, plants and animals [4, 5, 13–15]. In common with
many other innovative technologies, if any of these diseases
control techniques prove to be attractive alternatives to cur-
rently available methods this will inevitably result in the
disruption of established approaches. Furthermore, the
novelty of aspects of these experimental techniques has
the potential to sustain and amplify controversy both in
the general public and also among scientists [4, 16–21].
Consequently, engagement with stakeholders was repeat-
edly highlighted as of critical importance during the very
early consideration of experimental trials of all these bio-
technological approaches [4, 14, 16, 17, 22–29]. While
there continues to be an understandable focus on the per-
ceptions of the general public [16, 20, 22, 25, 30–32] there
has been less work on how scientists in diverse disciplines
and backgrounds perceive these novel biotechnological
techniques (though see [17, 33–38]).
Herein, we examine the opinions and awareness of
scientists on the topic of innovative biotechnological
techniques by conducting an invited written survey of
1889 individuals expert in various aspects of diseases
vectored to humans by arthropods. We show that
despite extensive media attention on global and re-
gional scales (e.g. [18, 21, 39–41]); awareness of keydevelopments is consistently low. This is despite the
fact that large numbers of the very scientists most
likely to be impacted by developments were included
in the survey (e.g. 389 of the sampled scientists
spent more than 50 % of their time working in
disease-endemic countries and report a substantial
focus on applied research). However, in only one in-
stance are we able to establish that awareness of pio-
neering developments exceeded 50 % on a national
or regional scale.
The survey respondents include a sizeable sample
from non-disease-endemic countries (where all these
biotechnology techniques were initially developed) and
the large communities of researchers in disease-endemic
countries (where these approaches may eventually be ap-
plied). Crucially, our sample includes a large number
(75 %) of disinterested scientists not directly involved in
the development of these biotechnological approaches,
but still expert in some aspect of vector-borne diseases.
By contrasting these and other partitions of respondents’
backgrounds it was possible to identify factors that ap-
pear to strongly influence their views towards these pio-
neering techniques. We find that factors including their
scientific expertise, citizenship, and their degree of pro-
fessional involvement in biotechnology all have profound
impacts on: (1) how and when they are first informed
about pioneering and experimental techniques, (2) their
attitude towards public engagement, and (3) their per-
ceptions of innovative technological approaches. Given
the limited capacity to communicate on global or con-
tinental scales demonstrated below, even with experts in
fields potentially directly impacted by this technology,
we argue that regional or nationally targeted engagement
strategies represent the most promising approach to in-
creasing the dissemination of information. Furthermore,
increasing the awareness of key developments in the well
established large pool of global scientists already expert
in the general topic of vectored diseases could be an im-
portant step in enhancing local scientists’ role as con-
tacts for decision makers and the public concerning
rapidly developing innovative technologies.
Methods
The e-mail addresses of corresponding authors were
harvested from the web-of-science (Thomson Reuters)
database using a series of keyword searches (Additional
file 1) to identify active researchers publishing in the
period 2005–2012 likely to be expert in at least one as-
pect of human or animal vectored disease. This list of e-
mails was further parsed to yield 14747 unique addresses
(Additional file 1). An invitation to participate in the
survey was sent 4th October 2012 with the subject head-
ing: Survey Invitation 'Transgenics and Vector-borne Dis-
eases' (Additional file 2). Further, 5 follow-up reminders
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file 2). The survey was conducted using the Question-
Pro web-based platform (QuestionPro.com). The full
text of the survey is provided in the Additional file 3.
Throughout the text relevant questions are identified
from the Additional file 3 by their respective number
prefixed by the letter ‘Q’. Data exploration and statis-
tical analysis was performed using JMP (SAS Insti-
tute) and Filemaker Pro (Filemaker Inc.). In total
there were 1889 completed surveys from respondents
indicating that their work was ‘somehow related to human
or animal diseases that are transmitted by arthropods’
(Q1). Only 27 substantially incomplete surveys were dis-
carded from analysis. The questionnaire was viewed
4046 times and started by 2771 responders. Most of
the scientists working on vector-borne disease re-
ported (Q2, Additional file 3) activities on: malaria
862 (45.6 %), dengue 778 (41.7 %), tick-borne diseases
377 (20 %), chikungunya 341(18.1 %), filaria 205
(10.9 %), Japanese encephalitis 191 (10.1 %), Chagas dis-
ease 317 (9 %), entomopathogenic fungi 70 (3.7 %),
and microsporidia 27 (1.4 %). Among them 1245
(65.9 %) reported working on malaria or dengue,
while 405 (21.4 %) declared activities on both dis-
eases. To assess the extent to which the research in-
terests of respondents reflected the output of the
whole field of vector research during the relevant
time period, title keyword searches were performed
using the web-of-science database (Additional file 4).
The correlation between this crude proxy for the re-
search output of the whole field and that reported
by the survey respondents was high, 0.91 for 2012
and 0.87 for the combined period 2005–2012, indi-
cating a highly representative sampling from this
perspective. Broadly speaking, all the diverse topics
were representatively sampled with only malaria be-
ing somewhat underrepresented (though given that a
prior smaller survey [33] specifically examined mal-
aria researchers perceptions of transgenic mosquitoes
the more extensive scope of the current data set
complements the earlier study). Among the respon-
dents, 720 (38.1 %) were citizens of a country en-
demic (Q3, Additional file 3) for either malaria or
dengue as defined by the WHO and CDC in (2013,
healthmap.org). Most respondents were resident in
countries they were citizens of, with only 287
(15.2 %) being resident aliens (Q4, Additional file 3).
Finally, a majority 1411 (75 %) of the respondent’s
research was unrelated to transgenesis (including
paratransgenesis, Q12, Additional file 3), with only
478 (25 %) reporting any involvement in transgenic
research. The substantial sample size of both these
groups permitted perceptual differences and similar-
ities between these groups to be robustly explored.Respondents selecting ‘No opinion’ or failing to se-
lect any of the given options are excluded from the
analysis of the relevant question.
Results and discussion
The large and diverse dataset of 1889 respondents to the
30 questions (see Additional file 3 for details) was ex-
plored, focusing on 3 major questions relevant to the
implementation of biotechnological vector control: (1)
How aware are scientists of novel scientific techniques
and how do they obtain information about pioneering
developments? (2) What are scientists’ attitudes towards
public communication and how might that impact the
role they play in engaging the communities in which they
live? (3) Should experts with similar professional
specialization be viewed as homogenous from the per-
spective of how they view science and technology? These
questions in the general area of public and scientific en-
gagement have been repeatedly highlighted as liable to
be important to the successful development of biotech-
nological approaches to controlling vectored diseases ap-
proaches [4, 14, 16, 17, 22–29]. However, it is also likely
to be highly relevant to a range of other innovative
technologies e.g., nanotechnology [42], synthetic biol-
ogy [43, 44] or climate engineering [45]. The particu-
lar importance of the above questions to the control
of vector-borne diseases partly stems from the fact
that biotechnological strategies (particularly those util-
izing recombinant DNA methods) in public health are
associated with new perceived risks and uncertainties,
possibly at a higher level than other currently
employed disease control techniques (vaccines, bed-
nets, prophylactic-drugs or indoor insecticide spray-
ing). This is probably also because most of these
novel biotechnologies require the long-term mainten-
ance of large numbers of manipulated insects disper-
sing by flight throughout human communities (in
some instances transgenics). Undoubtedly, the recur-
rent controversy about the use of genetically modified
crops in agriculture is also a source of defiance to-
wards extending genetic engineering to blood-feeding
insects living in human communities.
Obviously complex ethical, democratic and presenta-
tional challenges arise, many of which have been
considered in the context of public perceptions and
rights ([4, 14, 16, 17, 22–29, 46] though see [47, 48]).
However, this study focuses on the potentially more
tractable question of how scientists communicate with
other scientists about pioneering techniques and their
perceptions of them. The importance of genuinely bi-
directional exchange between the public and scientists is
widely recognized as crucial for the democratic legitim-
acy of scientific research. Sociological research has also
demonstrated the role this dialogue plays in the
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tions and for public trust in science [49–51]. While this
two-way engagement presumes a clear-cut distinction
between expert ‘scientists’ and the less well informed
‘public’ [52], the boundaries between these categories
appear from the survey results to be more inexact than
might be anticipated.
How aware are scientists of novel techniques and how do
they obtain information about pioneering developments?
To explore the awareness of scientists to pioneering de-
velopments, we asked respondents to recall when and
how they became aware of the first field trials of two dis-
tinct approaches to control dengue fever. The first was
the pioneering release of transgenic mosquitoes in 2009
in East End, Cayman Islands (an overseas U.K. territory
in the Caribbean, [7]). The second was a release in 2011
of mosquitoes transfected with a maternally inherited
endosymbiotic bacteria (Wolbachia pipentis) in Cairns,
Australia ([8] – note that the date of release was incor-
rectly given as October 2011 rather than January 2011 in
the survey text, see Additional file 3, Q22 for details and
explanations concerning the validity of the analysis.
From the responses given (Q20-24, Additional file 3) the
most striking observation is the consistently smallFig. 1 Regional and national awareness of the 2009 release of transgenic m
Pie charts represent when respondents recall learning of the 2009 release opercentage of scientists (considering only the ones not
directly involved in the releases) that were aware of ei-
ther release before it started, consistently <35 %
throughout the globe (Figs. 1, 2 and 3). The only excep-
tion is the Oceania region where pre-release awareness
exceeded 50 % for the 2011 Australia release; however,
this observation is largely driven by a high degree of
awareness in Australia (Fig. 3a). In summary, with re-
spect to either of these two pioneering trials, based on
our sampling, there is only compelling evidence for a
single nationally successful communication strategy and
none for any globally successful ones.
Surprisingly, a large percentage of scientists were un-
aware of either release at the time they participated in
the survey (>30-50 % in all regions, Fig. 1). This was
somewhat unanticipated, as both releases had attracted a
significant degree of global coverage in the general media
[41, 53–56] and scientific press [18, 19, 21, 39, 57]. How-
ever, our survey suggests that this media attention did not
translate into a high degree of global awareness among
scientists despite 3 years having elapsed since the
Cayman releases and 1 year since the Australia re-
leases. Examining how experts recall first learning about
these pioneering field releases we found a clear distinction
in the information sources utilized by the minority ofosquitoes in the Cayman Islands before and after they occurred (Q20).
f transgenic mosquitoes in the Cayman Islands
Fig. 2 Regional and national awareness of the 2011 release of Wolbachia-transfected mosquitoes in Australia before and after they occurred
(Q22). Pie charts represent when respondents recall learning of the 2011 release of Wolbachia-transfected mosquitoes in Australia
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who became aware afterwards (Fig. 4). For the majority of
scientists that became aware after releases had com-
menced there is a remarkable consistency in the
sources of information utilized, for both the Cayman
and Australia releases. In all instances, conventionalFig. 3 Regional and national awareness of pioneering mosquito releases b
occurred was uniformly low among expert scientists (<35 %) at national (3
awareness achieved in Australia for the 2011 release that occurred in Quee
Australian release (3b) should be viewed with caution as 66 % (Q20) and 7
are shown above the respective bars in (3a) and (3b). Individuals that were
where directly involved in it (Q21 and Q23) are excluded from the corresposcientific sources such as scientific meetings and articles
appear to play a predominant role (only the Cayman re-
lease appears to differ somewhat, probably due to in-
creased media coverage of the associated controversy
about the manner of the release, [18, 19, 21, 41]). With re-
spect to this high reliance on conventional scientificefore they occured. Awareness of either pioneering trial before releases
a) and regional (3b) levels. The only exception is the high national
nsland (Australia). The high awareness in the Oceania region for the
2 % (Q22) of respondents from this region are Australian. Sample sizes
not able to remember when they learnt about the release or that
nding figure
Fig. 4 Information sources utilized by scientists for pioneering releases of mosquitoes in 2009 in the Cayman Islands and in 2011 in Australia
(Q21 and Q23). In the small group of respondents aware of releases prior to their commencement (upper row of pie charts), a relatively high
proportion of individuals from disease non-endemic countries (right columns) had access to private information that was unavailable to scientists
from disease-endemic countries. Subsequent to releases, starting information sources utilized by scientists around the globe was fairly uniform.
See note in Text S3 about the impact of the start date of the Australia trial being incorrectly given in Q22 as Oct 2011 rather than Jan 2011
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ciated with high levels of trust, e.g., 69.3 % Universities
and 70.8 %, the WHO compared to 22.7 % for the media
and 28.7 % for private business (Q25, see also Additional
file 5).
Interestingly, for the minority of scientists that were
aware of either release before they commenced (<35 %),
it is clear that being privately informed is an important
route of information among scientists from non-
endemic countries (Fig. 4). However, these networks of
private communication do not appear to extend to the
same extent to scientists from disease-endemic countries
(Fig. 4). Finally, we observe that the widespread lack of
awareness of key developments illustrated in Fig. 4, also
extended to contemporaneous events in 2012. Respon-
dents were asked to state if they were aware of any
current open releases of transgenic mosquitoes (Q26).
Throughout the period of the survey in 2012 releases
were occurring in the Brazilian city of Juazeiro (Bahia).
However, only 29.1 % (N = 550) correctly responded ‘yes’
to this question, though among researchers involved in
transgenic research (Q13) this was somewhat higher at
43.3 % (N = 207). Interestingly, Brazilian scientists wereamong the most informed with 55.9 % (N = 87 of 152,
Q26) reporting being aware of the releases; however,
only 42.5 % (N = 37of 87, Q27) were right about the re-
leases happening in their own country. Though the Bra-
zilian release (starting in 2011) cannot be considered
pioneering in the same way as the Cayman 2009 or
Australia 2011 releases, the fact that awareness is highest
in the country where the trial is conducted is consistent
with the high national awareness of the 2011 Wolbachia
release in Australia (Fig. 2). Unfortunately, the survey
did not include any respondents resident in the Cayman
Islands, so it was impossible to determine if high local
awareness was also the case for the 2009 Cayman island
release. Four hundred and seven respondents incorrectly
identified at least one country other than Brazil as a re-
lease location in 2012 (Q27), these included Malaysia
(N = 120), Cayman Islands (N = 34), Australia (N = 96),
USA (N = 51), Thailand (N = 27), Mexico (N = 27), and
various African countries (N = 45). Why some of these
locations were repeatedly identified can in some in-
stances be reasonably be speculated upon. For example,
Malaysia and the Cayman Islands were the sites of earl-
ier releases (2009–2011) of transgenic mosquitoes that
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are likely to be related to a pending application to re-
lease transgenic mosquitoes in the Florida Keys [39].
Similarly, the incorrect identification of Mexico as an
open release site is likely related to contained outdoor
caged experiments in the Mexican state of Chiapas [58].
Respondents identifying Australia as a release site (N = 96)
probably mistook the Wolbachia releases in 2011 for a
transgenic technique [8]. Concerning the 45 respon-
dents identifying African countries as release locations,
it is less clear what might be the basis, as to our know-
ledge no such releases of manipulated mosquitos had
been officially proposed (though see [59]). It is possible
that this incorrect identification might be related to an
existing project with conventional sterile insect tech-
nique releases of mosquitoes in Sudan [60]. Interest-
ingly, of the 45 respondents indicating an African
release of transgenic mosquitos in 2012 only 8 were citi-
zens of African countries, indicating that this belief is
not likely to be based on local information. Collectively,
the widespread misunderstandings about what releases
were genuinely occurring in 2012 (Q26 & Q27) and the
low degree of awareness of two earlier pioneering re-
leases (Fig. 1, 2, Q20 & Q22) emphasize the fact that
even among the scientists basic knowledge can often be
quite incomplete and imprecise.
What are scientists’ attitudes towards public
communication and how might that impact the role they
play in engaging the communities in which they live?
Given the difficulties in achieving effective information dis-
semination in untargeted global communication strategiesFig. 5 Scientists opinions on how the public could be involved in scientific
responses to the question ‘How do you think citizens can be usefully involved
involve the public in science (77.9 % selected ‘very important’ or ‘priority iss
selected ‘very important’ or ‘priority issue’)it is probable that for public engagement to be effective it
will most likely need to rely, at least to some extent, on
local scientists (independent of any increased democratic
legitimacy it generates). Consequently, we were interested
to explore what scientists’ professional involvement with
the public looks like and how they value this activity. The
survey reveals that only a very small proportion of scientists
(5 %) communicate more than once a month with non-
specialist audiences (Q17), while more than 80 % have very
limited interactions or none at all (Additional file 6). This
occurs despite 53.8 % of respondents fully agreeing with
the value of communicating with the public about their
work compared to only 11 % who expressed no value in
doing so (Q15, Additional file 6). When asked how science
communication with the public could be improved, 77.9 %
of the respondents indicated the need for more creative
methods to educate and involve the public in science (Q19,
Fig. 5). This indicates that most experts in vectored diseases
consider the existing opportunities to communicate with a
non-scientific audience as inadequate to the task.
In keeping with the general desire of scientists to com-
municate with the public, almost all scientific articles
and reports on novel biotechnological approaches in-
cluded statements about the importance of public en-
gagement [4, 14, 16, 17, 22–29]. However, despite this
apparent consensus there is potentially a very broad
range of understandings of what might actually consti-
tute meaningful public engagement [26]. In order to ad-
dress this question we asked respondents to provide
their opinion on the specific question of when they
thought the public should be involved in projects (Q18).
Five response options ranging from early stages ‘beforedecision making (Q19). Radial bar chart representing the five
?’ There is a strong consensus for a need for new creative methods to
ue’). There is much less enthusiasm for the use of opinion polls (21.3 %
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for field testing is granted’ as well as ‘no need to involve
the public opinion’ were provided and multiple responses
were possible (Additional file 3). The results are pre-
sented in Fig. 6a as the earliest time point of public en-
gagement indicated by each respondent. Given the broad
scope of the response options provided, it is perhaps un-
surprising there is a wide range of opinions on the fun-
damentally important question of at what stage public
engagement should be initiated. There is however a
strong consensus 86 % (N = 1660) that public engage-
ment should commence ‘Before any permit application
for field testing is made’. More generally, it is striking
that responses do not approximate uni-modal distribu-
tions with a sizable number of respondents opting for
early engagement (‘before funding is requested’) with an-
other larger group opting for initiation at later stages
(‘After or simultaneously with the presentation of signifi-
cant results in scientific journals.’ or ‘Before any permit
application for field testing is made’). While the four di-
visions shown in Fig. 6a have similar means (2.77-3.08)
they exhibit varying degrees of skew towards or awayFig. 6 Scientists preferences for the earliest stage of public consultation in
citizens should become involved?’. Multiple responses were possible, but onl
whether respondents are a citizen of a malaria or dengue endemic country
insects (red) or not (green). b Country specific histograms from nations wit
colored as above. X-axis of all histograms provides a non-linear time series
the provided responses were selectedfrom early engagement; most striking is that scientists
from disease-endemic countries selected the earliest re-
sponse ‘1’ (‘before funding is requested’) more frequently
than did scientists from non-endemic countries (25 %
and 28 % versus 15 % and 18 %). Figure 6b also shows
large disparities are clearly discernable at national levels,
particularly with respects to the frequency of response
‘1’. For example 39 % of Kenyan respondents considered
that the public should be involved ‘before funding is re-
quested’, while in Australia and the USA the frequency
was 12 % and 18 % respectively. Clearly within such a
large dataset there is considerable potential for regional
and national variation; however, a quantitative awareness
of such predispositions could prove valuable when plan-
ning research, collaborations or guidelines in different
locations around the globe [24, 27, 29, 61].
Should experts with similar professional specialization be
viewed as homogenous from the perspective of how they
view science and technology?
The large size of the dataset and its breadth in terms of
the diversity of respondents permits the exploration ofscientific projects (Q18). Respondents were asked ‘When do you think
y the earliest is represented here. Histograms a, are grouped by
(Q3) and if their field of research (Q12) includes genetically modified
h the largest number of respondents per continent. Field of research is
from project conception to deployment. ‘NR’ indicates that none of
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plines and backgrounds. Possibly the most striking dif-
ferences relate to general perceptions about technology
and trust as scientists but also as citizens (Q24 & Q25,
reproduced from [62]). While there are numerous simi-
larities, there are also some striking differences. For ex-
ample, there is strong agreement between scientists who
are citizens of both endemic and non-endemic countries
that biotechnological progress will result in increased
opportunities Fig. 7a. However there is a striking con-
trast in their perceptions of whether science and tech-
nology make our lives change too fast, with a 71 % of
endemic scientists agreeing and only 20 % of non-
endemic scientists (Fig. 7b). While these observations do
not provide direct insight into how transnational collab-
oration should be conducted they do illustrate the po-
tential for fundamentally different viewpoints existing
even among expert scientists. Furthermore, it appears to
reflect that professional expertise as scientists does not
divorce them from the influence of the societies they live
in. In other words, scientists are also and in many cir-
cumstances, a public for other scientists.
The overall aim of this survey was to elucidate scien-
tists’ knowledge of and opinions on a currently emerging
technology at an early stage in its public and scientific
evaluation. This was done for the mass release of bio-
technologically manipulated mosquitoes for the control
of human diseases (e.g., dengue). Only 25 % of the scien-
tists in the survey indicated any direct involvement in
developing the technology, with the remaining 75 % be-
ing in related but distinct disciplines (many of which are
likely to be impacted should any novel methods prove to
be effective). Probably the most publically visible phase
of technology development commenced for the two
most advanced techniques in 2009 and 2011 with large-
scale experimental releases in human communities.
Overall the most striking result of the survey is the smallFig. 7 Perceptions of science and technology by scientists (Q24). Scientists
or disagree with the following statements about science, technology and socie
There is a very high degree of agreement that biotechnology will provide
citizens of disease-endemic countries and those of non-endemic countries
to the perceived desirability of the pace of change due to science and tecpercentage of scientists who were aware of either release
before it started, consistently less than 35 % throughout
the world (Fig. 1 and 2). This is despite a strong consen-
sus among respondents 86 % (N = 1660) that engage-
ment should commence ‘Before any permit application
for field testing is made’.
If experts working in the scientific field of vector con-
trol were not reached by any means of communication
prior to high-profile pioneering trials commencing we
can reasonably ask who then was reached at all? As the
intense public controversy around genetically modified
food shows, such a lack of engagement and inadequate
dissemination of accurate information can backfire at
the point of widespread implementation of new tech-
nologies [49, 63]. Equally, this lack of information calls
into question the ethics and the democratic legitimacy
of such research: if even scientific colleagues are not in-
formed, how then do potentially disagreeing parties have
a chance to voice their concerns? Furthermore, the
widespread misunderstandings about what releases were
genuinely occurring contemporaneously at the time of
the survey (Q26 & Q27) and the low degree of aware-
ness of two earlier pioneering releases (Figs. 1, 2 and 3,
Q20 & Q22) emphasize the fact that even among experts
basic knowledge is often incomplete and imprecise. This
clearly highlights significant gaps in the communication
processes occurring within the scientific community. Of
the scientists from disease non-endemic countries that
were informed about releases prior to them occurring
29 %-41 % obtain information via private sources (Fig. 2).
However, these private sources were not equally avail-
able to scientists in disease-endemic countries where
only 4 %-6 % accessed them (Fig. 4). This result points
towards continuing inequalities in information sharing
between scientists from the so-called developing and de-
veloped countries. Generally, the survey points to a need
to improve communication between peers (Figs. 1 and 2),were asked ‘As a scientist but also as a citizen, how much do you agree
ty?’. The specific statements are reproduced below the histograms.
new opportunities to future generations between scientists that are
. However there is a very striking contrast between the same groups as
hnology
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sources (including informal ones) to more fully include
experts in disease-endemic countries where this technol-
ogy is most likely to be used.
The survey showed that only scientists in the country
where a release took place were widely aware of develop-
ments (Australia, Figs. 1 and 2 and Brazil Q27). This un-
derlines the effectiveness of communication at local and
national levels in disseminating accurate information in
a timely manner. With respect to designing and imple-
menting future inclusive communication strategies the
success of the Australian ‘Eliminate Dengue’ project to
achieve 70 % awareness prior to an up coming develop-
ment (Fig. 2) is a notable achievement. Otherwise, the
survey results indicate the aim of raising awareness even
in groups of interested scientists is an extremely challen-
ging one using conventional communication approaches.
The survey results do however indicate that in attempting
to increase awareness among experts it may be productive
to strengthen traditional scientific communication methods
(scientific articles and meetings) rather than relying on gen-
eral media exposure (Fig. 4). This having been said, there
were two meetings specifically focused on the topic of
transgenic mosquitoes in the 9 months preceding the 2009
Cayman releases [28, 64], however this does not appear to
have translated into a high degree of awareness of the up-
coming pioneering development (Fig. 4). Expanding private
information networks – through scientific collaboration
and exchanges for instance - to include scientists from en-
demic countries would also appear to be a valuable compo-
nent in communicating with the countries where these
techniques are most likely to be experimentally tested or
applied.
The survey also questioned scientists about their
habits and opinions on communicating with the general
public. The survey reveals that only a very small propor-
tion of scientists (5 %) communicate more than once a
month with non-specialist audiences (Q17), while more
than 80 % have very limited interactions (Additional file 6).
This finding is consistent with data reported for bio-
medical researchers were <75 % reported being in
contact with journalists between 0–5 times a year
[65]. While we did not directly explore the reasons
for such a low level of engagement despite a high
value being placed upon it (by 53.8 % of respondents),
it is likely to require a multifaceted explanation. One
probable factor is of course lack of time for a task some
scientists might consider secondary to their research and
professional duties. Equally, it could reflect a limitation in
the access that many scientists have to effective means of
communication–for example media-outlets may be per-
ceived to be interested in only hearing from a small group
of high-profile specialists [65]. Such explanations would
need to be specifically investigated, but a betterunderstanding could be valuable in helping lower the bar-
riers between the majority of scientists enthusiastic about
communication and the interested public. In the context
of earlier studies detailing a correlation between the
number of science communication activities and the
perceived importance of public engagement [66, 67], it is
interesting to note that there is a positive correlation in
the current survey (Additional file 7) between the fre-
quency at which scientists report communicating with the
public (Q17) and a preference for earlier engagement of
the public in scientific projects (Q18).
However, regardless of this correlation, a remarkable
77.9 % of the surveyed scientists indicated the need for
more creative methods to educate and involve the public
in science (Q19, Fig. 5). This shows that most scientists
consider the existing opportunities to communicate with
non-scientific audiences as inadequate. The pervasive
desire for new and creative communication methods by
vector scientists is thus a major result of this survey. It
suggests a need for more tailor-made and imaginative
approaches to science communication [65], potentially
motivating collaborations between scientists, profes-
sional communicators, artists and other professions to
better use existing tools and to develop new ones
([68, 69] including online [36]). In the context of un-
conventional communication techniques, unexpectedly,
our survey has proven to be the largest single tool in glo-
bally disseminating information about key developments
in this field (see Fig. 1). While, the information conveyed
may be of a superficial nature it is noteworthy that 80 %
of respondents to a related survey of Nigeria scientists
stated that participation would inspire them to seek add-
itional information about transgenic mosquitoes [34].
In a broader sense the survey can be viewed as reflect-
ing that scientists are in many situations themselves a
'public' of science. Just as laypersons’ competences and
awareness of technological issues differ, it is often not
reasonable to assume that ‘a scientist’ understands all
relevant aspects- even in his or her own subfield of sci-
ence [70]. In this sense a simple binary division between
science and lay knowledge appears fraught. Instead we
see a clear need to place scientists among their society
and not outside of it [52]. More symmetrical communi-
cation and experimenting with creative ways of engaging
may prove productive in bringing the sciences and their
various publics into effective dialogue with each other.
Limitations of survey
Surveying a diverse set of professionals dealing with
vector-borne diseases and public health necessitates
making choices in sampling. The method of selecting for
corresponding authors of papers dealing with vector
control through the Web of Science has already been
used successfully in a previous survey [33]. Alternative
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tion to authors that have published a minimal number
of papers [71], or only consider authors of highly cited
papers [72, 73]. The underlying assumption would be
that a wider inclusion might have biased the survey by
including authors whose work on vector control is only
a peripheral part of their activity. However, as we chose
to include only corresponding authors this bias should
be limited. In addition, our wider sampling method has
the advantage to get young scientists involved in the sur-
vey instead of favoring a narrow selection of senior sci-
entists. This also avoids the risk of an overrepresentation
of domains where publication production is higher. Add-
itionally, we were explicitly keen to involve the wider
scientific community concerned with vector control, ra-
ther than a narrow selection, which tends to be biased
towards a one author, one voice system. Wider sampling,
we suggest, offers us the possibility to access the opin-
ions and experiences of a “community of practice” [74],
namely the scientists who share a profession and a com-
mon concern in their engagement in vector control. We
believe this is important as it does not restrict us to in-
clude only scientists working in transgenic vector con-
trol means, but allow us to include a representative
sample of scientists working on other technologies and
approaches of vector control (see also Additional file 4).
Information about science is only one factor in creat-
ing conditions for a democratic engagement with science
and scientific results. Accepting and trusting results and
biomedical interventions rather requires broad reflect on
the normative commitments of science, as well as its
economic and institutional distributions and politics
[49, 50, 70, 75, 76]. However, information about sci-
ence and public trials of scientific interventions is
nevertheless to be seen as one of the prerequisites for
such broader deliberations to take place. In this sense,
the present study focuses on one very limited aspect
of the public understanding and engagement with sci-
ence, but nevertheless a crucial one we suggest.
Conclusions
Questioning the general public about their knowledge,
perception and fears concerning novelties and innova-
tions is a well established approach in social science
studies [49, 50, 70, 75]. While communication ap-
proaches that aim at rectifying perceived deficiencies or
gaps in knowledge have repeatedly been shown to be
largely ineffective for the general public, as far as we are
aware it remains to be determined how useful they
might be for experts [77]. Here we took a converse ap-
proach by examining the perception and awareness of
scientists to a specific emerging technology.
This revealed a lack of communication among a sub-
stantial proportion of the scientific community and thatsome of the information that is circulating can be inaccur-
ate. This finding was common to the 74.7 % of scientists
in the study who were not directly involved in the devel-
opment of the technology, but also to the 26.3 % that re-
ported being actively involved. Our work also suggests
that scientists should be seen as publics in the societies
they live in and that a large majority of them would value
more extensive public engagement, with 79.9 % in favor of
finding more creative methods to do this. Making exten-
sive connections between specialists involved in technol-
ogy development and expert scientists in related fields is
clearly challenging. Initiatives such as biohacker spaces
[78] might be one of the many ways to open a space of
mutual engagement, including with the general public.
In summary our results strongly support the value of
prioritizing mutual knowledge building between special-
ists scientists involved in technology development and sci-
entists in related fields as a means to promote a genuinely
two-way dialogue. Furthermore, because technology spe-
cialists constitute only a very small proportion of the sci-
entific community, engaging with numerically much
larger pools of experts that are already locally established
has numerous practical advantages (this is in addition to
affording an increased legitimacy to decision making pro-
cesses by facilitating prominent roles for local scientists).
Clearly, an inclusive dialogue between scientists can only
facilitate its expansion to include the general public. While
our study focused on applications and early developments
in a specific biotechnology, most of our conclusions are
likely to have wide applicability to numerous diverse fields
such as nanotechnology, synthetic biology or climate
engineering.Additional files
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